Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Most human granulosa cell tumors express c-MET: A potential new therapeutic target.

Created on 24 Jun 2026

Authors

Edina A Wappler-Guzzetta, Daniel M Real, Shehla Aman, Chelsea Huang, Jeremy K Deisch, Laura J Denham

Published in

Physiology international. Jun 23, 2026. Epub Jun 23, 2026.

Abstract

The transmembrane receptor tyrosine kinase c-MET has a central role in granulosa cells in many physiological and pathological processes of granulosa cells, including cell survival and folliculogenesis. We therefore hypothesized that c-MET may be expressed in granulosa cell tumors (GCTs).
c-MET immunostaining was performed retrospectively on human GCT specimens, including adult (n = 19) and juvenile GCTs (n = 2). Data was collected on patient demographics, tumor stage, and size. Furthermore, staining intensity was analyzed by a staining intensity score, and the presence or absence of membranous staining was noted. Multivariate logistic regression was used for statistical analysis, with P < 0.05 being considered statistically significant. Juvenile GCTs were excluded from the statistical analysis.
Both cytoplasmic and membranous staining was seen in GCT tissues, with the majority (∼74%) of the adult and both juvenile cases showing positive membranous staining. As expected, vascular endothelial cells were also c-MET positive in the tumor tissue. Amongst the adult GCT patients, tumor mitotic activity was higher with older age (r = 0.531; P = 0.019). Also, smaller tumors had higher c-MET intensity scores (r = -0.579, P = 0.038).
Most GCTs were c-MET positive by immunostaining along with the vascular endothelial cells, highlighting the potential of c-MET inhibition as a therapeutic option in these tumors.

PMID:
42334874
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement